Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 131 users online. 33 members and 98 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

9 results in 0.0050 seconds.
Keywords
Members
Tags
review x
  •  

  • HHS Proposes Unprecedented Regulatory Reform through Retrospective Review

    HHS Proposes Unprecedented Regulatory Reform through Retrospective Review

    U.S. Department of Health and Human Services Proposes Unprecedented Regulatory Reform through Retrospective Review | site |



    (November 4, 2020) - - On November 4, 2020, the U.S. Department of Health and Human Services (HHS) published the following information:




    HHS Proposes Unprecedented Regulatory Reform through Retrospective Review



    Today, the Department of Health and Human Services issued a notice of proposed rulemaking requiring the Department to assess its regulations every ten years to determine whether they are subject to review under the Regulatory Flexibility Act (RFA), which requires regular review of certain significant regulations. If a given regulation is subject to the RFA, the Department must review the regulation every ten years to determine whether the regulation is still needed and whether it is having appropriate impacts. Regulations will expire if the Department does not assess and (if required)...
    See more | Go to post

  • U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19

    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19 | site |




    (March 30, 2020) - - Today (March 30, 2020), the U.S. Food and Drug Administration (FDA) published the following information:



    March 30, 2020

    Statement From:

    Commissioner of Food and Drugs - Food and Drug Administration

    Stephen M. Hahn M.D.

    The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed. Moreover, as in previous...
    See more | Go to post

  • FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications

    U.S. Food and Drug Administration Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications | site |




    (February 20, 2020) - - Today, the U.S. Food and Drug Administration (FDA) published the following information:


    Statement From:
    Director - CDRH Offices: Office of the Center Director
    Dr. Jeffrey E. Shuren MD, JD
    Director - Center for Drug Evaluation and Research
    Janet Woodcock M.D.



    Pharmacogenetic testing is a type of genetic test that in some instances can predict how a person will respond to specific medications. Thus, this type of testing offers promise for informing the selection or dosing of some medications for certain individuals. When there is sufficient scientific evidence demonstrating a relationship between how a person’s genes may impact their metabolism of a drug or how they may respond to the drug, this...
    See more | Go to post

  • National Transportation Safety Board Calls for Federal Review Process for Automated Vehicle Testing on Public Roads

    National Transportation Safety Board Calls for Federal Review Process for Automated Vehicle Testing on Public Roads| site |



    NTSB says ‘Inadequate Safety Culture’ Contributed to Uber Automated Test Vehicle Crash


    (November 19, 2019) - - Today (November 19, 2019), the National Transportation Safety Board (NTSB) published the following information: WASHINGTON (Nov. 19, 2019) - The National Transportation Safety Board called upon federal regulators Tuesday to create a review process before allowing automated test vehicles to operate on public roads, based upon the agency’s investigation of a fatal collision between an Uber automated test vehicle and a pedestrian. During a board meeting held to determine the probable cause of the March 18, 2018, Tempe, Arizona crash, the NTSB said an Uber Technologies Inc. division’s “inadequate safety culture” contributed to the March 18, 2018, nighttime fatal collision between an Uber automated test ...
    See more | Go to post

  • U.S. Department of State's review of This Week in Iran Policy, November 18-22

    U.S. Department of State's review of This Week in Iran Policy, November 18-22 | site |



    (November 22, 2019) - - Today, the U.S. Department of State's Office of the Spokesperson published the following account of This Week in Iran Policy, November 18-22:


    “As Iranians take to the streets in protest, the Ayatollahs in Tehran continue to use violence and imprisonment to oppress their people. The United States’ message is clear: the American people stand with the people of Iran.”
    – Vice President Mike Pence, Twitter, November 20







    SECRETARY POMPEO REMARKS IN RESPONSE TO THE ONGOING PROTESTS IN IRAN
    • The United States is monitoring the ongoing protests in Iran closely. We condemn strongly any acts of violence committed by this regime against the Iranian people and are deeply concerned by reports of several fatalities.
    • The Islamic Republic must cease violence against its own people and should
    ...
    See more | Go to post

  • Executive Office for Immigration Review Announces Largest Ever Immigration Judge Investiture

    Executive Office for Immigration Review Announces Largest Ever Immigration Judge Investiture




    (September 28, 2018) - - Today the U.S. Department of Justice published the following information: The Executive Office for Immigration Review (EOIR) announces the investiture of 46 immigration judges, including two assistant chief immigration judges, marking for the second month in a row the largest class in the agency’s history. “At this point in history your work is vitally important. The case backlog has reached more than 760,000. Great effort is surely needed,” said Attorney General Jeff Sessions at today’s investiture. “This situation is unacceptable. It cannot continue. Our nation’s chief executive supports you and all who strive to make our immigration system work.” Attorney General Jeff Sessions appointed these new judges after a thorough application process and we...
    See more | Go to post

  • Centers for Medicare and Medicaid Services Streamlines Medicaid Review Process, Achieves Significant Reduction in Approval Times

    Centers for Medicare and Medicaid Services Streamlines Medicaid Review Process, Achieves Significant Reduction in Approval Times




    (August 16, 2018) - - Today, the Centers for Medicare and Medicaid Services (CMS) announced significant improvements in managing the Medicaid program in partnership with states. Identified early as a priority for both the Trump Administration and the National Association of Medicaid Director’s (NAMD), CMS has implemented changes resulting in faster processing of state requests to make program or benefit changes to their Medicaid program through the state plan amendment (SPA) and section 1915 waiver review process. “With faster processing times and earlier communication, states now have much greater ability to manage their programs in an effective and predictable manner,” said CMS Administrator Seema Verma. “We want to ease bureaucratic requirement...
    See more | Go to post

  • U.S. Department of Veterans Affairs Offers Early Participation in a Faster New Claims Decision Review Process

    U.S. Department of Veterans Affairs Offers Early Participation in a Faster New Claims Decision Review Process




    Washington, DC - - (May 4, 2018) - - Today the U.S. Department of Veterans Affairs (VA) announced it is offering two opportunities for early participation in the new, more efficient claims decision review process outlined in the historic Veterans Appeals Improvement and Modernization Act of 2017. These two opportunities will allow eligible Veterans to receive a review of a decision on a claim much faster than the current appeals process. “VA is committed to transforming the appeals process,” said VA Acting Secretary Robert Wilkie. “This is evidenced by the success of Rapid Appeals Modernization Program which has seen over 12,000 Veterans opt-in. In addition, the Board of Veterans’ Appeals has issued approximately 46,000 decisions this fiscal year — nearly 23,000 more ...
    See more | Go to post

  • U.S. Department of the Treasury and The Office of Management and Budget Update Tax Regulatory Review Process

    U.S. Department of the Treasury and The Office of Management and Budget Update Tax Regulatory Review Process




    Washington, DC - - (April 12, 2018) - - The U.S. Department of the Treasury and the Office of Management of Budget (OMB) today released a Memorandum of Agreement (MOA) creating a new framework for the review of tax regulations. The modernized framework meets the twin objectives of increasing the economic analysis and review of tax rules while preserving timely tax guidance for taxpayers. “We are very pleased with the agreement announced today, which is an important step in advancing President Trump’s tax and regulatory reform agenda,” said Treasury Secretary Steven T. Mnuchin. “This updated review framework will increase scrutiny of regulations most likely to impose new costs, while preserving Treasury’s ability to ensure taxpayers receive timely, clear rules and g...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    HHS Proposes Unprecedented Regulatory Reform through Retrospective Review
    by Staff Reporter 1
    U.S. Department of Health and Human Services Proposes Unprecedented Regulatory Reform through Retrospective Review | site |



    (November 4, 2020) - - On November 4, 2020, the U.S. Department of Health and Human Services (HHS) published the following information:




    HHS Proposes Unprecedented Regulatory Reform through Retrospective Review



    Today, the Department of Health and Human Services issued a notice of proposed rulemaking requiring the Department to assess its regulations every ten years to determine whether they are subject to review under the Regulatory Flexibility Act (RFA), which requires regular review of certain significant regulations. If a given regulation is subject to the RFA, the Department must review the regulation every ten years to determine whether the regulation is still needed and whether it is having appropriate impacts. Regulations will expire if the Department does not assess and (if required)...
    11-06-2020, 06:53 AM
  • Staff Reporter 1
    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19
    by Staff Reporter 1
    U.S. Food and Drug Administration Expedites Review of Diagnostic Tests to Combat COVID-19 | site |




    (March 30, 2020) - - Today (March 30, 2020), the U.S. Food and Drug Administration (FDA) published the following information:



    March 30, 2020

    Statement From:

    Commissioner of Food and Drugs - Food and Drug Administration

    Stephen M. Hahn M.D.

    The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed. Moreover, as in previous...
    04-01-2020, 03:20 AM
  • Staff Reporter 1
    FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications
    by Staff Reporter 1
    U.S. Food and Drug Administration Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications | site |




    (February 20, 2020) - - Today, the U.S. Food and Drug Administration (FDA) published the following information:


    Statement From:
    Director - CDRH Offices: Office of the Center Director
    Dr. Jeffrey E. Shuren MD, JD
    Director - Center for Drug Evaluation and Research
    Janet Woodcock M.D.



    Pharmacogenetic testing is a type of genetic test that in some instances can predict how a person will respond to specific medications. Thus, this type of testing offers promise for informing the selection or dosing of some medications for certain individuals. When there is sufficient scientific evidence demonstrating a relationship between how a person’s genes may impact their metabolism of a drug or how they may respond to the drug, this...
    02-21-2020, 09:30 AM
  • Staff Reporter 1
    National Transportation Safety Board Calls for Federal Review Process for Automated Vehicle Testing on Public Roads
    by Staff Reporter 1
    National Transportation Safety Board Calls for Federal Review Process for Automated Vehicle Testing on Public Roads| site |



    NTSB says ‘Inadequate Safety Culture’ Contributed to Uber Automated Test Vehicle Crash


    (November 19, 2019) - - Today (November 19, 2019), the National Transportation Safety Board (NTSB) published the following information: WASHINGTON (Nov. 19, 2019) - The National Transportation Safety Board called upon federal regulators Tuesday to create a review process before allowing automated test vehicles to operate on public roads, based upon the agency’s investigation of a fatal collision between an Uber automated test vehicle and a pedestrian. During a board meeting held to determine the probable cause of the March 18, 2018, Tempe, Arizona crash, the NTSB said an Uber Technologies Inc. division’s “inadequate safety culture” contributed to the March 18, 2018, nighttime fatal collision between an Uber automated test ...
    11-25-2019, 07:13 AM
  • Staff Reporter 1
    U.S. Department of State's review of This Week in Iran Policy, November 18-22
    by Staff Reporter 1
    U.S. Department of State's review of This Week in Iran Policy, November 18-22 | site |



    (November 22, 2019) - - Today, the U.S. Department of State's Office of the Spokesperson published the following account of This Week in Iran Policy, November 18-22:


    “As Iranians take to the streets in protest, the Ayatollahs in Tehran continue to use violence and imprisonment to oppress their people. The United States’ message is clear: the American people stand with the people of Iran.”
    – Vice President Mike Pence, Twitter, November 20







    SECRETARY POMPEO REMARKS IN RESPONSE TO THE ONGOING PROTESTS IN IRAN
    • The United States is monitoring the ongoing protests in Iran closely. We condemn strongly any acts of violence committed by this regime against the Iranian people and are deeply concerned by reports of several fatalities.
    • The Islamic Republic must cease violence against its own people and should
    ...
    11-23-2019, 02:15 AM

Menu

Collapse

Menu

Collapse

Working...
X